The Company expects to announce a trading update for the year ended 31 December 2024 before the end of February 2025, which will include the outlook for 2025.

The company expects to announce its interim results for the six months ended 30 November 2024 on Wednesday 29 January 2025.

The company will host a presentation relating to its preliminary results Monday, 2 December 2024. (Please note that the result will be announced on Friday, 29 November).

The company will host a presentation relating to its interim results on Thursday, 21 November 2024.

Management will be hosting a live online presentation relating to the Q3 trading update on Thursday 31 October 2024.

The Company will release its preliminary results for the year ended 30 June 2024 will be announced on Monday 21 October 2024.

Online investor presentation: via your Investor Meet Company at 11:30am. Investors can sign up to Investor Meet Company and add to meet Tristel Plc, by clicking here.

The company will release its interim results for the six months ended 30 June 2024, on Monday 30 September 2024.

New date / time for Investor presentation: Monday 14 October 2024 at 4:00 p.m. BST.

The Company will be hosting a virtual investor day on Wednesday 9 October 2024

The event will be held via a Zoom webinar and will feature presentations on Polarean's lung functional Xenon MRI platform, its clinical use and future utility, as well as the Company's commercial strategy and future plans. The event is open to all.

The Company announces that it expects to release its preliminary results for the year ended 30 June 2024 on Tuesday 8 October.

The Group will be announcing its interim results for the six months ended 31 July 2024 on Wednesday 2 October 2024.

The investor presentation will be held on Monday, 7 October 2024 at 11am BST.

The Company will report its unaudited financial results for the six months ended 30 June 2024 on Thursday, 26 September 2024.

The Company will release its unaudited interim results for the six months ended 30 June 2024 on Wednesday, 25 September 2024.

Management expects to announce its unaudited results for H1 2024 on Tuesday 17 September 2024 through the digital platform, Investor Meet Company.  

The Company will release its interim results for the six months ended 30 June 2024 on Tuesday 10 September 2024.  

Management confirms that the Group’s interim results for the six months ended 30 June will be announced on Tuesday 10 September 2024.

The company confirms that it will be announcing its half year results for the six months ended 30 June 2024 on Wednesday, 4 September 2024.

The company will announce its interim results for the six months ended 30 June 2024 on Wednesday 4 September 2024.

The company will announce its preliminary results for the year ended 31 May 2024 on Wednesday 31 July 2024.

Investors can sign up to Investor Meet Company for free and add to meet Hargreaves Services plc here.

Management will host a Capital Markets Event for analysts, institutional investors, and media on Wednesday 17 July 2024 at 10.00 am – 12.30 pm (BST)

Analysts, institutional investors and media are welcome to attend the in-person event. Due to restrictions on numbers, it will not be possible for all interested parties to attend in-person, however, a live webcast will be available on the Company's website for retail investors and others to view the presentations here.

To register your interest for the event or webcast, please contact Walbrook PR on +44 20 7933 8780 or email [email protected]. A recording of the presentation will be made available on the Company's website after the event.

The company announce its audited results for the period ended 31 December 2023 on Friday 28 June 2024.

Investor presentation will be held via the Investor Meet Company platform on Wednesday, 10 July at 11am BST.

Investors can sign up to Investor Meet Company for free and add to meet ProBiotix Health plc here.

The company announce that Geoff Robertson, CEO will provide a live presentation relating to the Company’s Half Year Results via Investor Meet Company on 9 July 2024.

Management will hold the company’s AGM on 20 June 2024 at 2pm BST

The company will announce its final results for the year ended 31 December 2023 on Tuesday 4 June 2024.

The company will announce its audited final results for the year ended 31 December 2023 on Monday, 3 June 2024.

The company will announce its audited financial results for the year ended 31 December 2023 on Thursday, 30 May 2024.

The Company will host a Capital Markets Day on Wednesday 22 May 2024.

In person attendance at the Capital Markets Day is for institutional investors and analysts only. 

A live streamed webinar of the Capital Markets Day is available to all investors. Online attendees can register using the link here.  

Management will provide a presentation on Monday, 20 May 2024.

Investors can sign up to Investor Meet Company for free and add to meet OptiBiotix Health plc here.

Management will provide an update on the business and current trading on on Thursday, 16 May.

Investors can sign up to Investor Meet Company for free and add to meet Fusion Antibodies plc here.

Management will announce its audited full year results for the year ended 31 December 2023 on Wednesday 15 May 2024.

Management will report its third quarter fiscal year 2024 financial results on Wednesday, May 15, 2024 before U.S. market open.

A corresponding conference call and live webcast will be held at 8:30 a.m. (ET) / 1:30 p.m. (BST) on the day.

To register please click here. 

INFEX is hosting a live webinar to provide deeper insight into the Company, its strategy and lead pipeline assets on Thursday 9 May 2024 at 3pm BST.

The event will include presentations from the Infex senior management team along with a Q&A.

Please check here for more information and to register your interest: https://www.infextx.com/infex-to-present-webinar-on-broader-pipeline-and-growth-strategy/

Management expects to announce its audited results for the year ended 30 November 2023, on Wednesday 8 May 2024.

Management will announce its results for the 12 months ended 31 December 2023 on Thursday 25 April 2024.

Investor presentation to review the results and prospects will be held at 3pm on Tuesday 30 April 2024.

Management will announce its final results for the year ended 30 September 2023 on Tuesday 30 April 2024.

Management will announce its final results for 31 December 2023 on Tuesday 23 April 2024.

Management will announce its audited results for the year ended 31 December 2023 on Thursday 18 April 2024.

Management will announce its final results for the year ended 30 September 2023 on Friday 12 April 2024.

Management will announce its full year results for the twelve months ended 31 December 2023 on Tuesday 9 April 2024.

Management will announce its interim results for the six months ended 31 December 2023 on 28 March 2024.

The Company will provide a live presentation on Friday, 5 April 2024.

Management will announce its Final results for the 12 months ended 31 December 2023 on Wednesday 20 March 2024.